glycopeptoids have been reported.7 Usually modification
of glycoconjugates could be achieved by olefin cross
metathesis (CM),8 bioorthogonal ligation,9 the use of
transistion metal complexes,10 cross-coupling reactions,11
and azideÀalkyne cycloadditions.12
been extended to the aqueous phase where site-selective
modification of proteins bearing allyl sulfides has been
accomplished.8
The synthesis of glycopeptoids reported here involved
attaching sugar derivatives to alkenyl moiety-containing
peptoids through solid-phase CM (Figure 1). Peptoids
with various side chains were prepared on beads with
strategically positioned alkenyl components in different
chain lengths. O-Linked sugar-alkenyl derivatives (16À30)
were prepared from mannose, galactose, and glucose pre-
cursors (Scheme 1). Free sugars were peracetylated or
perbenzoylated and underwent selective anomeric depro-
tection by methylamine in THF.15 The obtained lactols
(8À11) were treated with trichloroacetonitrile in DBU to
produce glycosyl trichloroacetimidates (12À15). Glycosyl
imidate donors were activated by trimethylsilyltriflate,
followed by nucleophilic attack of primary alcohols such
as allyl alcohol, 3-buten-1-ol, 4-penten-1-ol, and 3-methyl-
3-buten-1-ol to furnish four sugar derivatives from each
monosaccharide in high yields.
CM has emerged as one of the most powerful tools in the
preparation of carbonÀcarbon bonds over the past decade
and has provided a convenient synthetic route to simple
alkenes and substituted precursors. The well-defined olefin
metathesis catalysts prepared by Grubbs et al. may tolerate
a variety of functional groups and have facilitated metath-
esis chemistry.13 Since the reactants and products of olefin
metathesis are alkenes, great care must be taken to design
reactions so as to avoid unnecessary side products. CM has
been intensively studied in solution, with few examples
reportedinthesolid phase.14 Theversatility ofCMhasalso
Scheme 1. Synthesis of Alkene-Containing Sugar Derivatives
Figure 1. General schematic representation for the solid-phase
synthesis of glycopeptoids via CM.
(7) (a) Saha, U. K.; Roy, R. Tetrahedron Lett. 1995, 36, 3635.
(b) Roy, R.; Saha, U. K. Chem. Commun. 1996, 2, 201. (c) Kim, J. M.; Roy,
R. Tetrahedron Lett. 1997, 38, 3487. (d) Marcaurelle, L. A.; Bertozzi,
C. R. Chem.;Eur. J. 1999, 5, 1384. (e) Burger, K.; Boettcher, C.;
Hennig, L.; Essawy, S. A. Monatsh. Chem. 2004, 135, 865. (f) Comegna,
D.; De Riccardis, F. Org. Lett. 2009, 11, 3898. (g) Seo, J.; Michaelian, N.;
Owens, S. C.; Dashner, S. T.; Wong, A. J.; Barron, A. E.; Carrasco,
M. R. Org. Lett. 2009, 11, 5210.
(8) (a) Lin, Y. A.; Chalker, J. M.; Floyd, N.; Bernardes, G. J. L.;
Davis, B. G. J. Am. Chem. Soc. 2008, 130, 9642. (b) Chalker, J. M.; Lin,
Y. A.; Boutureira, O.; Davis, B. G. Chem. Commun. 2009, 3714. (c) Lin,
Y. A.; Chalker, J. M.; Davis, B. G. J. Am. Chem. Soc. 2010, 132, 16805.
(9) (a) Saxon, E.; Bertozzi, C. R. Science 2000, 287, 2007. (b) Gupta,
S. S.; Kuzelka, J.; Singh, P.; Lewis, W. G.; Manchester, M.; Finn, M. G.
Bioconjugate Chem. 2005, 16, 1572.
(10) (a) Antos, J. M.; Francis, M. B. Curr. Opin. Chem. Biol. 2006, 10,
253. (b) Tilley, S. D.; Francis, M. B. J. Am. Chem. Soc. 2006, 128, 1080.
(11) Antos, J. M.; Francis, M. B. J. Am. Chem. Soc. 2004, 126, 10256.
(12) (a) Wang, Q.; Chan, T. R.; Hilgraf, R.; Fokin, V. V.; Sharpless,
K. B.; Finn, M. G. J. Am. Chem. Soc. 2003, 125, 3192. (b) Lin, P.-C.;
Ueng, S.-H.; Tseng, M.-C.; Ko, J.-L.; Huang, K.-T.; Yu, S.-C.; Adak,
A. K.; Chen, Y.-J.; Lin, C.-C. Angew. Chem., Int. Ed. 2006, 45, 4286.
(c) Van Kasteren, S. I.; Kramer, H. B.; Jensen, H. H.; Campbell, S. J.;
Kirkpatrick, J.; Oldham, N. J.; Anthony, D. C.; Davis, B. G. Nature
2007, 446, 1105. (d) Norgren, A. S.; Budke, C.; Majer, Z.; Heggemann,
C.; Koop, T.; Sewald, N. Synthesis 2009, 488.
To study solid-phase CM, 4-mer peptoids (31À32) were
first prepared with terminal units of allylamine or buteny-
lamine (3-buten-1-amine) on Rink Amide LL resin
(100À200 mesh, 0.4 mmol/g) (Scheme 2). The terminal
amine of the peptoids was capped by di-tert-butyl dicar-
bonate. The three most commonly used olefin metathesis
catalysts G1, G2, and HG2 were tested (Figure 1).16
Peptoids (31À32) with terminal allyl or butenyl groups
were reacted with mannosides (20À21) with allyl or bute-
nyl groups inthe presenceofthe catalystsunder microwave
or reflux conditions (for details, see Supporting
Information). The catalyst was used at 2À5 mol %, and
5 mol % was suitable for the catalysis of solid-phase CM.
Increasing the catalyst loading to 10 mol % increased the
homodimerization of the sugars in solution. G1 and G2
provided much lower yields; HG2 gave a higher yield.
In addition, allylÀallyl (with allyl units each from the
peptoids and the sugar derivatives) combinations were
(13) Grubbs, R. H. Handbook of Metathesis; Wiley-VCH: Weinheim,
Germany, 2003, and references therein.
(14) (a) Andrade, R. B.; Plante, O. J.; Melean, L. G.; Seeberger, P. H.
Org. Lett. 1999, 1, 1811. (b) Blackwell, H. E.; Clemons, P. A.; Schreiber,
S. L. Org. Lett. 2001, 3, 1185. (c) Kanemitsu, T.; Seeberger, P. H. Org.
Lett. 2003, 5, 4541. (d) Testero, S. A.; Mata, E. G. Org. Lett. 2006, 8,
4783. (e) Poeylaut-Palena, A. A.; Testero, S. A.; Mata, E. G. J. Org.
Chem. 2007, 73, 2024.
(15) (a) Brimble, M. A.; Kowalczyk, R.; Harris, P. W. R.; Dunbar,
P. R.; Muir, V. J. Org. Biomol. Chem. 2008, 6, 112. (b) Sato, K.; Oka, N.;
Fujita, S.; Matsumura, F.; Wada, T. J. Org. Chem. 2010, 75, 2147.
(16) Khan, S. N.; Kim, A.; Grubbs, R. H.; Kwon, Y. U. Org. Lett.
2011, 13, 1582.
B
Org. Lett., Vol. XX, No. XX, XXXX